Vertex Pharmaceuticals stock price objective was boosted, triggering a requirement for 13F filings regarding stock ownership.
1 report, 1 independent
Updated Jun 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vertex Pharmaceuticals stock price objective was boosted, triggering a requirement for 13F filings regarding stock ownership.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Carmen Bozic, CMO of Vertex Pharmaceuticals, sold company stock on June 23, 2026.Sub-event
SEC requires 13F filings for Vertex stock ownership after price objective boost.1 source
Keep exploring
The entities involved
-
Vertex Pharmaceuticals
American pharmaceutical company
-
Royal Bank of Canada
financial institution in Canada